Date
Title
View
08 May 19
Expedeon AG: Expedeon AG adds ELISA-ONE(TM) next generation cell signalling assay technology to product offering (news with additional features)
View
25 Apr 19
Expedeon AG: Expedeon Reports Financial Results for Fiscal Year 2018 – Financial Guidance Met (news with additional features)
View
14 Mar 19
Expedeon AG: Expedeon Announces Supervisory Board Changes (news with additional features)
View
08 Jan 19
Expedeon AG licenses Lightning-Link(R) Rapid Biotinylation technology to Cell Guidance Systems in supply agreement (news with additional features)
View
08 Nov 18
Expedeon AG reports strong third quarter 2018 financial results (news with additional features)
View
07 Nov 18
Expedeon AG signs supply and license agreement with Quanterix Corporation for access to proprietary immunoassay technology (news with additional features)
View
27 Sep 18
Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology (news with additional features)
View
18 Sep 18
Expedeon AG comments on recent share price development (news with additional features)
View
11 Sep 18
Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay (news with additional features)
View
30 Aug 18
Expedeon AG secures GBP 5 million in debt financing (news with additional features)
View
29 Aug 18
Expedeon AG to present at upcoming investor conferences (news with additional features)
View
09 Aug 18
Expedeon AG (formerly SYGNIS AG) reports financial results for the first six months of 2018 and successful execution of name change (news with additional features)
View